An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer.
about
Systemic Inflammatory Response Based on Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker in Bladder CancerC-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic ReviewClinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancerClinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.Interaction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases.Proposed follow up programme after curative resection for lower third oesophageal cancer.The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer.The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapyA new inflammation index is useful for patients with esophageal squamous cell carcinoma.Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinomaPrognostic influence of pre-operative C-reactive protein in node-negative breast cancer patients.The combination of platelet count and neutrophil lymphocyte ratio is a predictive factor in patients with esophageal squamous cell carcinomaNeutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.Wheel Balanced Cancer Therapy for Longer Than 21 Days Can Have a Positive Effect on the Survival of Patients with Stage IV CancerClinicopathologic significance of expression of nuclear factor-κB RelA and its target gene products in gastric cancer patientsCorrelates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors.The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer.Blood count and C-reactive protein evolution in gastric cancer patients with total gastrectomy surgeryPrealbumin/CRP Based Prognostic Score, a New Tool for Predicting Metastasis in Patients with Inoperable Gastric Cancer.C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases.Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer.The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder.The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer.Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy.Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: results from the ITACa trialPretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantationElevated biomarkers of inflammation are associated with reduced survival among breast cancer patientsElevated pre-treatment levels of high sensitivity C-reactive protein as a potential prognosticator in patients with colorectal cancer.The prognostic significance of the preoperative full blood count after resection of colorectal liver metastases.Correlations between functional imaging markers derived from PET/CT and diffusion-weighted MRI in diffuse large B-cell lymphoma and follicular lymphomaAssociation between the inflammatory biomarker, C-reactive protein, and the response to radiochemotherapy in patients with esophageal cancerGlasgow prognostic score predicts therapeutic outcome after hepatic resection for hepatocellular carcinomaTime course of serum C-reactive protein levels during induction chemoradiotherapy and its correlation with treatment response and survival in patients with advanced esophageal squamous cell carcinoma.The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction.A New Preoperative Prognostic System Combining CRP and CA199 For Patients with Intrahepatic Cholangiocarcinoma.Is the Glasgow Prognostic Score Applicable to Both Early- and Advanced-Stage Gastric Cancers?Evaluation of the metabolic response to open and minimally invasive resection of the oesophagus due to oesophageal cancer
P2860
Q26765951-7F38AB4A-5DB8-4A88-8C2C-E21640DD33A4Q26771557-CE75CD1F-E766-4F76-9E72-F2336497D4F7Q33448971-9B0AC4FE-2FD1-493E-B381-BD10791F1CD1Q33577505-47EC97BE-C72D-467A-AABC-86A5DB2B10FAQ33679628-158B7668-9094-49F3-9F47-1E91A7C1395FQ34133427-3F5C110A-9EE3-41A0-BF5B-8AC80636DA73Q34198587-0E4286F6-AE18-4D8D-AC57-8664233C0AC9Q34241072-F0D71627-4502-4CE3-9009-6FB3CFBD1CD7Q34352751-69348913-B1B7-4D9B-A581-CA3C099945C0Q34392042-FFB19882-C145-4F87-9A39-0AD49B8AA03BQ34395838-1810699E-EAF0-4C1C-8CA6-9124F1BEF872Q34478562-47B4BAD5-AD88-4675-AA65-E702F9B1D417Q34806672-F7AA1253-76B9-4256-96CD-E4267D7A6B9DQ36070272-E365655A-25EE-4638-867C-EC058FEF59B7Q36233861-F64773F9-BC89-4DF5-97A5-B49078ACA128Q36469182-D2F4F7DA-9F35-43B6-BE9E-FE49573EC091Q36494189-0BC149C5-24E9-4A39-92B3-EBB840EE6E7CQ36549787-10174531-9E11-432A-9903-C2430B17CDBAQ36557940-C04E14C5-0C14-461C-8473-DE8C4D17E598Q36609762-05B1C289-2A14-491C-BAFB-EA59DFDC4D6FQ36610116-3CFAC8A8-DA4E-4EC3-9672-7D075681B4C3Q36611805-7C4C18FE-2C5E-4166-88F6-D563B1D2DA89Q36612383-884A073C-0610-426D-A032-CDDDAA4AF04FQ36881262-7DFA2947-CFE3-4036-9520-5B6CDCA272B0Q36962915-4DA8D23C-F261-4AB6-AC34-C7927BA7168AQ37157282-358CF24E-30C3-4B28-A22B-5AB4619307ABQ37280710-A7791E02-8F4F-4F43-A1D8-B551A2CC0411Q37313233-34DE731F-8890-4A04-9CD2-C53371B39995Q37337938-CB62E768-9EFB-443B-B622-36F3B85CD3CAQ37483861-E197C940-70F2-4B2B-A8DA-5BE2A9EF8E61Q39655246-696E0922-3CF1-4666-B90E-B4A3543ECE68Q40978049-D1955F24-3662-4EC2-8611-1857D25128A0Q41919033-92A6E589-FB8D-4EB7-96EE-E8FB028C4FACQ42031892-D62DFB82-9B68-42EF-B62A-75E049533B79Q45851469-D75A89D8-81FA-46AB-ACAB-AF0FAE9E889CQ47215342-6347DB55-0927-4472-8A54-FC534F9ADAEAQ57494743-CE7B4AE9-FDAF-4E75-A700-A8D3DE761B70
P2860
An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
An elevated C-reactive protein ...... for gastro-oesophageal cancer.
@ast
An elevated C-reactive protein ...... for gastro-oesophageal cancer.
@en
type
label
An elevated C-reactive protein ...... for gastro-oesophageal cancer.
@ast
An elevated C-reactive protein ...... for gastro-oesophageal cancer.
@en
prefLabel
An elevated C-reactive protein ...... for gastro-oesophageal cancer.
@ast
An elevated C-reactive protein ...... for gastro-oesophageal cancer.
@en
P2093
P2860
P356
P1476
An elevated C-reactive protein ...... for gastro-oesophageal cancer
@en
P2093
Crumley AB
McKernan M
Shearer CJ
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603150
P407
P577
2006-06-01T00:00:00Z